Alpha 2.0
Login Register
» Authors » O Cirioni

O Cirioni

Explore the profile of O Cirioni including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 67
Citations 699
Followers 0
Related Specialties
Infectious Diseases
Microbiology
Pharmacology
Top 10 Co-Authors
A Giacometti
G Scalise
F Barchiesi
R Ghiselli
M S Del Prete
F Mocchegiani
V Saba
F Orlando
M Fortuna
C Silvestri
Published In
J Antimicrob Chemother
Eur J Clin Microbiol Infect Dis
Antimicrob Agents Chemother
Peptides
Eur J Vasc Endovasc Surg
Affiliations
Soon will be listed here.
Recent Articles
1.
Long-term Maraviroc Therapy and Limited Side Effects in an HIV-1 Experienced Patient: Six Years of Antiretroviral Observation
Cirioni O, Weimer L, Fragola V, Giacometti A, Sozio F
West Indian Med J . 2015 Apr; 63(7):785-7. PMID: 25867566
No abstract available.
2.
A Simplified HAART Regimen with Raltegravir and Lamivudine, and Pharmacokinetic Interactions with a Combined Immunosuppressive Therapy with Tacrolimus and Everolimus in an HIV/HCV/HBV/HDV Patient after Liver Transplantation
Cirioni O, Weimer L, Fragola V, Giacometti A, Ancarani F, Maracci M, et al.
West Indian Med J . 2015 Apr; 63(7):779-84. PMID: 25867565
In this case report, we examine the impact of a simplified two-drug highly active antiretroviral therapy (HAART) regimen of raltegravir and lamivudine in a patient co-infected with human immunodeficiency virus...
3.
Sustained increase of serum creatine phosphokinase levels and progressive muscle abnormalities associated with raltegravir use during 32-week follow-up in an HIV-1 experienced patient on simplified HAART regimen, intolerant to protease inhibitors...
Cirioni O, Weimer L, Fragola V, Giacometti A, Gabrielli E, Marchionni E, et al.
West Indian Med J . 2014 Apr; 62(4):377-9. PMID: 24756601
Sustained increase of serum creatine phosphokinase (CPK) concentrations and muscle abnormalities have been reported in patients taking raltegravir (RAL). In this report, we describe a case of sustained and asymptomatic...
4.
Virological failure at one year in triple-class experienced patients switching to raltegravir-based regimens is not predicted by baseline factors
Bucciardini R, DEttorre G, Baroncelli S, Ceccarelli G, Parruti G, Weimer L, et al.
Int J STD AIDS . 2012 Jul; 23(7):459-63. PMID: 22843997
We evaluated rates and determinants of virological failure in triple-class experienced patients receiving raltegravir-based regimens from a national observational study over 48 weeks, defined by any one of the following:...
5.
Antimicrobial properties of distinctin in an experimental model of MRSA-infected wounds
Simonetti O, Cirioni O, Ghiselli R, Goteri G, Orlando F, Monfregola L, et al.
Eur J Clin Microbiol Infect Dis . 2012 Jun; 31(11):3047-55. PMID: 22729599
The aim of this study was to evaluate the efficacy of distinctin in the management of cutaneous methicillin-resistant Staphylococcus aureus (MRSA) wound infections in an experimental mouse model. Wounds, made...
6.
In vitro activity and in vivo efficacy of tigecycline alone and in combination with daptomycin and rifampin against Gram-positive cocci isolated from surgical wound infection
Silvestri C, Cirioni O, Arzeni D, Ghiselli R, Simonetti O, Orlando F, et al.
Eur J Clin Microbiol Infect Dis . 2011 Dec; 31(8):1759-64. PMID: 22160846
The aim of this work was to determine the in vitro activity of tigecycline and its bactericidal effect for a large number of Gram-positive cocci, as well as to investigate...
7.
Effectiveness of antimicrobial photodynamic therapy with a single treatment of RLP068/Cl in an experimental model of Staphylococcus aureus wound infection
Simonetti O, Cirioni O, Orlando F, Alongi C, Lucarini G, Silvestri C, et al.
Br J Dermatol . 2011 Feb; 164(5):987-95. PMID: 21275941
Background: Chronic leg ulceration is a common health problem. It is well known that a clinically relevant bacterial load in chronic cutaneous wounds interferes significantly with the normal process of...
8.
In vitro activity of the lipopeptide PAL-Lys-Lys-NH2, alone and in combination with antifungal agents, against clinical isolates of Candida spp
Kamysz E, Simonetti O, Cirioni O, Arzeni D, Ganzetti G, Campanati A, et al.
Peptides . 2010 Nov; 32(1):99-103. PMID: 21055432
Candida albicans is known to be the organism most often associated with serious fungal infection, but other Candida spp. are emerging as clinical pathogens associated with opportunistic infections. Among antimycotic...
9.
Daptomycin and rifampin alone and in combination prevent vascular graft biofilm formation and emergence of antibiotic resistance in a subcutaneous rat pouch model of staphylococcal infection
Cirioni O, Mocchegiani F, Ghiselli R, Silvestri C, Gabrielli E, Marchionni E, et al.
Eur J Vasc Endovasc Surg . 2010 Sep; 40(6):817-22. PMID: 20869272
Objective: To investigate the efficacy of daptomycin and rifampin either alone or in combination in preventing prosthesis biofilm in a rat model of staphylococcal vascular graft infection. Design: Prospective, randomised,...
10.
In vitro activity of Tachyplesin III alone and in combination with terbinafine against clinical isolates of dermatophytes
Simonetti O, Ganzetti G, Arzeni D, Campanati A, Marconi B, Silvestri C, et al.
Peptides . 2009 Jul; 30(10):1794-7. PMID: 19591887
Aim of our study was to investigate the in vitro effects of Tachyplesin III (TP), a potent disulfide-linked peptide, in dermatophytes infections, with respect to or in combination with terbinafine...